Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
12
Number of overlapping holdings
40.0%
% of FBT's 31 holdings also in CANC
25.5%
% of CANC's 47 holdings also in FBT
Overlap by Weight
Sector Drift (FBT minus CANC)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FBT |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
ARGENX SE ADR | 3.8% | 4.3% | 3.8% |
 |
INCYTE CORP | 3.7% | 4.2% | 3.7% |
|
GILEAD SCIENCES INC | 3.6% | 5.4% | 3.6% |
|
ILLUMINA INC | 3.3% | 3.8% | 3.3% |
|
EXELIXIS INC | 4.6% | 3.0% | 3.0% |
Position Highlights (Non-Overlapping Exposures)
FBT Overweight Relative to CANC
|
NATERA INC | 4.2% |
|
CORCEPT THERAPEUTICS INC | 4.2% |
|
INTRA-CELLULAR THERAPIES INC | 3.7% |
|
NEUROCRINE BIOSCIENCES INC | 3.6% |
|
ACADIA PHARMACEUTICALS INC | 3.6% |
|
CATALYST PHARMACEUTICAL PART | 3.6% |
|
REPLIGEN CORP | 3.6% |
|
WATERS CORP | 3.5% |
|
SAREPTA THERAPEUTICS INC | 3.5% |
|
UNITED THERAPEUTICS CORP | 3.4% |
FBT Underweight Relative to CANC
 |
ASTRAZENECA PLC | -5.2% |
|
REVOLUTION MEDICINES, INC. | -4.6% |
|
BLUEPRINT MEDICINES CORP. | -4.3% |
 |
CHUGAI PHARMACEUTICAL CO LTD | -3.3% |
|
DAIICHI SANKYO CO LTD | -3.1% |
|
REGENERON PHARMACEUTICALS | -3.0% |
|
MERCK & CO. INC. | -2.9% |
|
AGIOS PHARMACEUTICALS INC | -2.9% |
|
CRISPR THERAPEUTICS AG | -2.5% |
|
GUARDANT HEALTH, INC. | -2.4% |